Neuberger Berman Group
CCXI

Neuberger Berman Group’s ChemoCentryx, Inc. CCXI Stock Holding History

Neuberger Berman Group’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-57,000
Closed -$3.12M – 1747
2020
Q3 		$3.12M Buy
+57,000
New +$3.07M ﹤0.01% 970

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Neuberger Berman Group's CCXI Position: Q4 2020 in Review

Neuberger Berman Group sold out of ChemoCentryx, Inc. (CCXI) in Q4 2020, closing a stake of 57,000 shares — an estimated $3.12M sold.

Neuberger Berman Group first reported a position in CCXI in Q3 2020 and held it in 1 quarter. The position peaked at $3.12M in Q3 2020. 196 funds tracked by Wall St. Rank hold CCXI as of Q4 2020.

  • Neuberger Berman Group reported no remaining ChemoCentryx, Inc. position as of Q4 2020 after selling out during the quarter.
  • Neuberger Berman Group sold 57,000 ChemoCentryx, Inc. shares in Q4 2020, an estimated $3.12M.
  • Neuberger Berman Group first reported a position in ChemoCentryx, Inc. in Q3 2020 and held it in 1 quarter.
  • Neuberger Berman Group's ChemoCentryx, Inc. position peaked at $3.12M in Q3 2020.
  • 196 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2020.

Based on Neuberger Berman Group's 13F filing for Q4 2020, filed 10 Feb 2021.